Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Bancroft

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Biometrics|February 6, 2013
Estimation of false discovery rate using sequential permutation p-valuesTim Bancroft, Chuanlong Du, Dan Nettleton
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 19, 2015
A Real-World Study of Switching From Allopurinol to Febuxostat in a Health Plan DatabaseAylin Altan, Aki Shiozawa, Tim Bancroft, et al.
BMC Health Services Research|December 26, 2014
The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patientsMirko Sikirica, Serban R Iorga, Tim Bancroft, et al.
Pituitary|October 12, 2012
Real-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databasesTanya Burton, Elisabeth Le Nestour, Tim Bancroft, et al.
Journal of Medical Economics|July 9, 2010
Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United StatesMallik Angalakuditi, Eric Edgell, Anthony Beardsworth, et al.
Clinical Therapeutics|February 10, 2016
Health Care Resource Utilization, Costs, and Persistence in Patients Newly Diagnosed as Having Nonvalvular Atrial Fibrillation and Newly Treated With Dabigatran versus Warfarin in the United StatesTim Bancroft, Jonathan Lim, Cheng Wang, et al.
Clinical Therapeutics|March 28, 2018
Burden of Illness Associated with Tenosynovial Giant Cell TumorsTanya M Burton, Xin Ye, Emily D Parker, et al.
Journal of Managed Care & Specialty Pharmacy|March 26, 2016
Impact of a Novel Cost-Saving Pharmacy Program on Pregabalin Use and Health Care CostsCarolyn Martin, Kevin Odell, Joseph C Cappelleri, et al.
The Journal of Rheumatology|October 3, 2012
Annual medical costs and healthcare resource use in patients with systemic sclerosis in an insured populationDaniel E Furst, Ancilla W Fernandes, Serban R Iorga, et al.
JAMA|January 13, 2016
Correction of Description of MMR Vaccine Receipt Coding and Minor Errors in MMR Vaccine and Autism StudyAnjali Jain, Jaclyn Marshall, Ami Buikema, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Biometrics|February 6, 2013
Estimation of false discovery rate using sequential permutation p-valuesTim Bancroft, Chuanlong Du, Dan Nettleton
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 19, 2015
A Real-World Study of Switching From Allopurinol to Febuxostat in a Health Plan DatabaseAylin Altan, Aki Shiozawa, Tim Bancroft, et al.
BMC Health Services Research|December 26, 2014
The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patientsMirko Sikirica, Serban R Iorga, Tim Bancroft, et al.
Pituitary|October 12, 2012
Real-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databasesTanya Burton, Elisabeth Le Nestour, Tim Bancroft, et al.
Journal of Medical Economics|July 9, 2010
Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United StatesMallik Angalakuditi, Eric Edgell, Anthony Beardsworth, et al.
Clinical Therapeutics|February 10, 2016
Health Care Resource Utilization, Costs, and Persistence in Patients Newly Diagnosed as Having Nonvalvular Atrial Fibrillation and Newly Treated With Dabigatran versus Warfarin in the United StatesTim Bancroft, Jonathan Lim, Cheng Wang, et al.
Clinical Therapeutics|March 28, 2018
Burden of Illness Associated with Tenosynovial Giant Cell TumorsTanya M Burton, Xin Ye, Emily D Parker, et al.
Journal of Managed Care & Specialty Pharmacy|March 26, 2016
Impact of a Novel Cost-Saving Pharmacy Program on Pregabalin Use and Health Care CostsCarolyn Martin, Kevin Odell, Joseph C Cappelleri, et al.
The Journal of Rheumatology|October 3, 2012
Annual medical costs and healthcare resource use in patients with systemic sclerosis in an insured populationDaniel E Furst, Ancilla W Fernandes, Serban R Iorga, et al.
JAMA|January 13, 2016
Correction of Description of MMR Vaccine Receipt Coding and Minor Errors in MMR Vaccine and Autism StudyAnjali Jain, Jaclyn Marshall, Ami Buikema, et al.
Pageof 5